TAKE Solutions announced the appointment of Dr Steve Galen as the Global Head of Clinical at Navitas Life Sciences, a TAKE Solutions Enterprise. He will be based out of Princeton, NJ.
Steve has over 20 years of pharmaceutical and CRO industry experience. He has held key strategic and leadership roles in Covance, PRA, lnVentiv Health and Syneos Health. Steve has been instrumental in scaling global businesses, leading successful tech-enabled clinical operations and has a strong track record of operations leadership, project management, technology and innovation in global roles.
Steve holds a Ph.D. in Materials Engineering from Drexel University, Pennsylvania.
Commenting on the appointment, Srinivasan H R, Vice Chairman and Managing Director TAKE Solutions said, "We are happy to welcome Steve Galen, Global Head of Clinical to our TAKE team. Steve's in-depth pharmaceutical industry experience and thought leadership in the Clinical space will further enhance our well-established market presence as we further widen our global footprint."
Ram Yeleswarapu, President and CEO, TAKE Solutions said, "Steve Galen is an accomplished pharma Senior Leader with an impressive track record in project management, clinical operations as well as global study start up experience in major pharmaceutical companies and CROs. His expertise in heading innovation and leading successful tech-enabled clinical operations projects is vital as TAKE spearheads on its 2021 growth strategy. On behalf of the board, I welcome him to the company."
Shares of TAKE SOLUTIONS LTD. was last trading in BSE at Rs.148.8 as compared to the previous close of Rs. 144.8. The total number of shares traded during the day was 12074 in over 175 trades.
The stock hit an intraday high of Rs. 150 and intraday low of 147.15. The net turnover during the day was Rs. 1804166.